Physicians' guide to interactions between glaucoma and systemic medications

被引:0
|
作者
Gottfredsdottir, MS [1 ]
Allingham, RR [1 ]
Shields, MB [1 ]
机构
[1] DUKE UNIV,CTR EYE,BRYON GLAUCOMA CLIN,DURHAM,ENGLAND
关键词
chronic open-angle glaucoma; systemic disorders; glaucoma medications; systemic medications; drug interactions;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To develop a Physicians' Guide to assist clinicians in the concomitant use of glaucoma and systemic medications. Methods: The records of 100 consecutive patients with chronic open-angle glaucoma were retrospectively studied to determine the most common systemic medications that are prescribed in this population. The ten most common drug classes were then used to construct a guide to potential interactions aid side effects when these medications are used concomitantly with glaucoma drugs. Results: Eighty-four patients were receiving 1 or more medications (a mean of 3.5) for a mean of 2.6 systemic conditions. Systemic antihypertensive agents was the most common class of drugs, being used by 48 patients. Aspirin, the most common single systemic drug, was being used by 25 patients. Conclusions: A high percentage of patients with chronic open-angle glaucoma receive a wide variety of medications for coexisting systemic disorders. The concomitant use of glaucoma and systemic medications creates the potential for drug interactions, as well as side effects for both groups of drugs, for which the Physicians' Guide may be beneficial.
引用
收藏
页码:377 / 383
页数:7
相关论文
共 50 条
  • [1] SYSTEMIC DRUG-INTERACTIONS WITH TOPICAL GLAUCOMA MEDICATIONS
    GERBER, SL
    CANTOR, LB
    BRATER, DC
    SURVEY OF OPHTHALMOLOGY, 1990, 35 (03) : 205 - 218
  • [2] Medical management of glaucoma and interaction between glaucoma and systemic medications
    Traustadottir, Valgerour Dora
    Tryggvadottir, Elin Bjork
    Olafsdottir, Olof Birna
    Guomundsson, Malsteinn
    Gottfreosdottir, Maria Soffia
    LAEKNABLADID, 2019, 105 (04): : 163 - 169
  • [3] Systemic medications and glaucoma patients
    Covert, D
    Robin, AL
    Novack, GD
    OPHTHALMOLOGY, 2005, 112 (10) : 1849 - 1850
  • [4] GLAUCOMA MASKED BY SYSTEMIC MEDICATIONS
    GEYER, O
    LOEWENSTEIN, A
    LAZAR, M
    ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (06) : 1236 - 1236
  • [5] MINIMIZING THE SYSTEMIC EFFECTS OF GLAUCOMA MEDICATIONS
    FARRELL, TA
    GERIATRICS, 1991, 46 (05) : 61 - &
  • [6] Systemic side effects of glaucoma medications
    Arbabi, Amirmohsen
    Bao, Xuan
    Shalaby, Wesam Shamseldin
    Razeghinejad, Reza
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2022, 105 (02) : 157 - 165
  • [7] SYSTEMIC ADVERSE REACTIONS TO GLAUCOMA MEDICATIONS
    FRAUNFELDER, FT
    MEYER, SM
    INTERNATIONAL OPHTHALMOLOGY CLINICS, 1989, 29 (03) : 143 - 146
  • [8] OCULAR AND SYSTEMIC COMPLICATIONS FROM GLAUCOMA MEDICATIONS
    FRAUNFELDER, FT
    MEYER, M
    SOUTHERN MEDICAL JOURNAL, 1988, 81 (09) : S48 - S48
  • [9] SYSTEMIC EFFECTS OF MEDICATIONS USED TO TREAT GLAUCOMA
    EVERITT, DE
    AVORN, J
    ANNALS OF INTERNAL MEDICINE, 1990, 112 (02) : 120 - 125
  • [10] Cautious interpretation of the associations between systemic hypertension, antihypertensive medications and the risk of developing glaucoma
    Mohamed-Noriega, Jibran
    Scott, Andrew
    Pinto, Luis Abegao
    Rousseau, Antoine
    Garway-Heath, David
    JOURNAL OF HYPERTENSION, 2017, 35 (11) : 2328 - 2329